ADVERSE-EFFECTS OF CHEMOTHERAPEUTIC-AGENTS USED IN TROPICAL MEDICINE

被引：10

作者：

COOK, GC

机构：

[1] Hospital for Tropical Diseases, London, NW1 0PE, St Pancras Way

来源：

DRUG SAFETY | 1995年 / 13卷 / 01期

关键词：

D O I：

10.2165/00002018-199513010-00005

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Traditionally, many of the chemotherapeutic agents used in tropical medicine have possessed limited efficacy and serious adverse effects. This scenario has been revolutionised by the introduction into clinical parasitology of the benzimidazole compounds, praziquantel (and other schistosomicidal agents) and ivermectin for helminthiases, and the 5-nitroimidazoles for protozoan infections. An effective armamentarium against Plasmodium spp. infections, especially P. falciparum, is receding as widespread multiple drug resistance becomes common-place. Although management of several more exotic parasitic infections, including trypanosomiasis, leishmaniasis and onchocerciasis remains unsatisfactory, several newer and relatively non-toxic preparations (including eflornithine and ivermectin) are now available, and offer optimism. However, there remains a very long way to go before a single preparation is available to combat all major protozoan and/or helminthic infections; such an agent would also need to be 100% effective when given as a single dose, safe not only in the healthy adult but also during pregnancy and lactation, stable at high ambient temperature and relatively low in cost.

引用

页码：31 / 45

页数：15

共 139 条

[1]

Cook G.C., Presidential address: Evolution: the art of survival, Trans R Soc Trop Med Hyg, 88, pp. 4-18, (1994)

[2]

Cook G.C., Use of antiprotozoan and anthelmintic drugs during pregnancy: side-effects and contra-indications, J Infect, 25, pp. 1-9, (1992)

[3]

Cook G.C., Problems associated with antiprotozoan and anthelmintic chemoprophylaxis/chemotherapy during pregnancy [letter], J Infect, 26, (1993)

[4]

Horton J., The use of antiprotozoan and anthelmintic drugs during pregnancy and contraindications [letter], J Infect, 26, (1993)

[5]

Auer H., Kollaritsch H., Juptner J., Et al., Albendazole and pregnancy, Appl Parasitol, 35, (1994)

[6]

Izu R., Aguirre A., Goicoechea A., Et al., Photoaggravated allergic contact dermatitis due to topical thiabendazole, Contact Dermatitis, 28, (1993)

[7]

Flisser A., Madrazo I., Plancarte A., Et al., Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel [letter], Lancet, 342, (1993)

[8]

Montero R., Flisser A., Madrazo I., Et al., Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel, Mutat Res, 305, (1994)

[9]

Burnham G.M., Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi, Trans R Soc Trop Med Hyg, 87, (1993)

[10]

Kar S.K., Patnaik S., Kumarswami V., Et al., Side reactions following ivermectin therapy in high density bancroftian microfilaraemics, Acta Trop Basel, 55, pp. 21-31, (1993)

← 1 2 3 4 5 6 7 8 9 10 →